Robert Ticktin

CIK: 0001613482

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PMVP

PMV Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

PMVP
PMV Pharmaceuticals, Inc.
Mar 5, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
319.3K shares-
PMVP
PMV Pharmaceuticals, Inc.
Jul 1, 2025
Sale(S)
Direct
23.2K shares at avg. $1.06$25K

		Type	Shares	Price		Ownership
Mar 5, 2026	PMVP PMV Pharmaceuticals, Inc.	Award(A) Employee Stock Option (right to buy)	319,270	-	-	Direct
Jul 1, 2025	PMVP PMV Pharmaceuticals, Inc.	Sale(S)	23,151	$1.06	$24,651	Direct

1-2 of 2 transactions

About Ticktin Robert

Ticktin Robert (SEC CIK 0001613482) files insider reports with the SEC as General Counsel & COO of PMV Pharmaceuticals, Inc. (PMVP).

Signal8 holds 3 ownership filings by Ticktin Robert (1 Form 3, 2 Form 4), filed between Apr 23, 2025 and Mar 9, 2026. Those filings report 2 transactions, from Jul 1, 2025 to Mar 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ticktin Robert's filings is in PRINCETON, NJ.

Recent filings by Ticktin Robert

Mar 5, 2026: Grant or award of PMVP derivative securities (Form 4, code A).
Jul 1, 2025: Open-market sale of PMVP shares (Form 4, code S).

Other insiders filing for PMV Pharmaceuticals, Inc. (PMVP)

How to read Form 4 transaction codes